Graduation Year

2026

Document Type

Master's Thesis

Degree

Master of Science

Program

Biological Science

Partner Organization

Buck Institute for Research on Aging

Program Director

Patti Culross, MD, MPH

First Reader

Pankaj Kapahi, PhD

Second Reader

Yifan Xiang, MD, PhD

Abstract

Menopause— characterized by the cessation of ovarian function and, subsequently, menstruation — is a significant risk factor for osteoporosis, type II diabetes, cardiovascular disease, and Alzheimer’s disease in women. Despite extensive characterization of menopausal phenotypes, the metabolic basis contributing to menopause has not been systematically investigated. To investigate this, we utilized the Mendelian randomization (MR) approach to identify metabolites causally associated with age at menopause by leveraging five large-scale metabolomics genome-wide association studies (GWAS) against two independent GWAS built on menopausal timing. Our research identified 66 significant metabolite-menopause causal associations, with uridine identified as the strongest regulator of delaying menopause (Beta = 3.83, p-value = 2.29×10-4). To investigate SNP-level interactions, we extracted MR-derived significant SNPs and related genes, performed Qiagen Ingenuity Pathway Analysis (IPA), revealing enrichment in phospholipid biosynthesis and cancer-related signaling networks linked to uridine-associated variants. To validate this finding, dietary uridine supplementation in Drosophila revealed improved fecundity trajectory and extended lifespan without affecting healthspan. Together, our study identifies novel metabolic drivers of menopause timing and provides convergent genetic and experimental evidence supporting uridine as a regulator of delayed reproductive aging.

Available for download on Thursday, May 31, 2029

Share

COinS